These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23478571)

  • 21. Low molecular weight heparins in patients with renal insufficiency.
    Symes J
    CANNT J; 2008; 18(2):55-61. PubMed ID: 18669012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Error in body weight estimation leads to inadequate parenteral anticoagulation.
    dos Reis Macedo LG; de Oliveira L; Pintão MC; Garcia AA; Pazin-Filho A
    Am J Emerg Med; 2011 Jul; 29(6):613-7. PubMed ID: 20825842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher Tinzaparin Dosing Is Needed to Achieve Target Anti-Xa Levels in Pediatric Cardiac Intensive Care Patients.
    Roeleveld PP; van der Hoeven A; de Wilde RB; Eikenboom J; Smiers FJ; Bunker-Wiersma HE
    Pediatr Crit Care Med; 2016 Mar; 17(3):203-9. PubMed ID: 26808621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of thromboelastography in monitoring low molecular weight heparin therapy in the coronary care unit.
    White H; Sosnowski K; Bird R; Jones M; Solano C
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):304-10. PubMed ID: 22473047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children.
    Nowak-Göttl U; Bidlingmaier C; Krümpel A; Göttl L; Kenet G
    Br J Pharmacol; 2008 Mar; 153(6):1120-7. PubMed ID: 17906688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates.
    Goldsmith R; Chan AK; Paes BA; Bhatt MD;
    J Perinatol; 2015 Oct; 35(10):852-4. PubMed ID: 26181722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low molecular weight heparins and unfractionated heparin after successive subcutaneous administration. A randomized controlled study in healthy volunteers.
    Pindur G; Heiden M; Köhler M
    Arzneimittelforschung; 1993 May; 43(5):542-7. PubMed ID: 8392345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD; Lakhani M; El Rouby S; Cavusoglu E
    J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic indications of low molecular weight heparins].
    Samama MM; Michaut-Paterno F
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experiences with low-molecular weight heparins in pediatric patients.
    Hofmann S; Knoefler R; Lorenz N; Siegert G; Wendisch J; Mueller D; Taut-Sack H; Dinger J; Kabus M
    Thromb Res; 2001 Sep; 103(5):345-53. PubMed ID: 11553367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
    Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
    ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.
    Montalescot G; Collet JP; Tanguy ML; Ankri A; Payot L; Dumaine R; Choussat R; Beygui F; Gallois V; Thomas D
    Circulation; 2004 Jul; 110(4):392-8. PubMed ID: 15249498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value and impact of anti-Xa activity monitoring for prophylactic dose adjustment of low-molecular-weight heparin during pregnancy: a retrospective study.
    Boban A; Paulus S; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2017 Apr; 28(3):199-204. PubMed ID: 27254442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.
    Clark NP; Delate T; Cleary SJ; Witt DM
    Thromb Res; 2010 May; 125(5):402-5. PubMed ID: 19699510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital.
    Andrade-Campos MM; Montes-Limón AE; Fernandez-Mosteirin N; Salvador-Osuna C; Torres M; Lucia-Cuesta JF; Rubio-Felix D
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):194-8. PubMed ID: 23358201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing and monitoring of enoxaparin (Low molecular weight heparin) therapy in children.
    Ignjatovic V; Najid S; Newall F; Summerhayes R; Monagle P
    Br J Haematol; 2010 Jun; 149(5):734-8. PubMed ID: 20346012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.